Financials
- Fiscal year
- 2025
- Total assets
- €1.2m
- Profit
- €108,754
- Solvency
- 43.2%
Total assets▲ 4.8%
Net result
20182025
Summary
RED ONE PHARMA has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €513,675 and a net result of €108,754. Equity is growing by ~21.6% per year across the filed fiscal years. Its solvency ranks better than 57% of 10645 sector peers (fiscal year 2025). The company has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals.
Overview
What they do
Retail sale of pharmaceutical products
NACE 47730
1 site
How big
€1.2mtotal assets 2025
- Equity
- €513,675
- Profit
- €108,754
Financially healthy?
Holding: outside the score modelProbability: sector outside the model
Who decides
- Holdings
- 1
Accounts 43 d early0 of 2 deeds read
SignalsLatest accounts filed on timeShow the evidence
Checked score
Outside the general model
Holding: general score not applicable
The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-06-2026, 43 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
43 d early
2024
42 d early
2023
30 d early
2022
46 d early
2021
45 d early
2020
43 d early
2019
42 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 42 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 18 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
- Annual accounts filedfiscal year 2025 · abbreviated…
- Equity above €500,000Eq €513,675 ▲26.9%
- Annual accounts filedfiscal year 2024 · full…
Key points
By topic
Network & group
- Subsidiaries
- 1
1 subsidiary
Timeline
- Events
- 15
- Since
- 2019
- Next accounts
- by 31-07-2027
- 18-06-2026Annual accounts filed
- 31-12-2025Equity above €500,000
- 19-06-2025Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 16-11-2017
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What changed in the latest annual accounts?What changed What held for this company on a given day: board, seat, name?Company as of a date
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.